The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents-Reference-Cited by-同舟云学术

The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents

Published:2013-09-12 Issue:11 Volume:122 Page:1900-1913
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Dos Santos Cedric¹,McDonald Tinisha¹,Ho Yin Wei¹,Liu Hongjun¹,Lin Allen¹,Forman Stephen J.²,Kuo Ya-Huei¹,Bhatia Ravi¹

Affiliation:

1. Division of Hematopoietic Stem Cell and Leukemia Research and

2. Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Abstract

Key Points SRC family kinases are activated in AML stem/progenitor cells and contribute to AML stem cell survival and proliferation. Combined inhibition of SFKs and c-KIT with dasatinib enhances p53-mediated elimination of AML stem cells.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/11/1900/1331469/1900.pdf

Reference49 articles.

1. Drug therapy for acute myeloid leukemia.;Tallman;Blood,2005

2. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.;Bonnet;Nat Med,1997

3. Stem cells, cancer, and cancer stem cells.;Reya;Nature,2001

4. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice.;Sarry;J Clin Invest,2011

5. Stem cell gene expression programs influence clinical outcome in human leukemia.;Eppert;Nat Med,2011

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off-target pharmacological activity at various kinases: Potential functional and pathological side effects;Journal of Pharmacological and Toxicological Methods;2023-09

2. Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia;Annals of Medicine;2023-04-18

3. Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies;Anti-Cancer Agents in Medicinal Chemistry;2023-04

4. Sunitinib-based Proteolysis Targeting Chimeras (PROTACs) reduced the protein levels of FLT-3 and c-KIT in leukemia cell lines;Bioorganic & Medicinal Chemistry Letters;2022-12

5. ATP-site inhibitors induce unique conformations of the acute myeloid leukemia-associated Src-family kinase, Fgr;Structure;2022-11